The Department of Clinical Microbiology and Immunology
Sackler School of Medicine


Dr. Rina Rosin-Arbesfeld from the Department of Clinical Microbiology and Immunology, Sackler School of medicine, Tel Aviv University has gained her BSc, MSc and PhD at the Tel Aviv University. During her education Rina specializing in studying molecular aspects of retroviruses. Following completing her postdoctoral studies at the MRC-LMB, Cambridge, UK she returned to the Tel-Aviv University. During her postdoctoral she focused of studying molecular aspects of signaling pathways in health and disease.

Rosin-Arbesfeld's research group have been involved in developing a novel treatment strategy based on mutation stop-codon read-through in key genes. This strategy is suitable for treatment of a large numbers of diseases, among them are different cancer types such as colorectal cancer.

This read-through platform is currently used to develop specific drugs against spinal muscular atrophy (SMA) by BioBlast Pharma and is in clinical trials as a treatment for patients suffering from Familial Adenomatous Polyposis (FAP).

In other aspects of her work Dr. Rosin-Arbesfeld is focusing of different aspects of the Wnt pathway and is currently establishing methods for prolonging the life span of Red Blood Cells (RBCs).